•$CrowdStrike (CRWD.US)$+3.8% (secures Provisional Authorization to Operate at Impact Level 4; says it expects to achieve $5 bln in annual recurring revenue)
•$WideOpenWest (WOW.US)$+3.7% (co is exploring options including a sale according to Bloomberg)
•$MediciNova (MNOV.US)$+2.4% (announces secondary analysis of Phase 2 Trial of MN-166 (ibudilast) in Alcohol Use Disorder Published in Alcoholism: Clinical and Experimental Research)
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.